PMA device
Consulta Crt-P, Syncra CRT-P
Medtronic, Inc. · Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode (OJX, Class III) · First FDA decision Jun 4, 2012, newest May 24, 2013Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Consulta Crt-P Syncra"
MAUDE reports
0
Brand "Consulta Crt-P Syncra", since 2015
PubMed studies
0
Mentioning "Consulta Crt-P Syncra"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Consulta Crt-P, Syncra CRT-P
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- CONSULTA CRT-P, SYNCRA CRT-PPMA supplement
P010015-S190 · Decided May 24, 2013 · 87 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent left ventricular (lv) pacemaker electrode (OJX) · Cardiology
- CONSULTA CRT-P, SYNCRA CRT-PPMA supplement
P010015-S162 · Decided Feb 19, 2013 · 182 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent left ventricular (lv) pacemaker electrode (OJX) · Cardiology
- CONSULTA CRT-P, SYNCRA CRT-PPMA supplement
P010015-S157 · Decided Jun 4, 2012 · 89 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent left ventricular (lv) pacemaker electrode (OJX) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Pacemakers: Single-Chamber and Dual-Chamber Permanent Cardiac PacemakersNational analysisReview closedCAG-00063R3Updated Sep 17, 2026
- Single Chamber and Dual Chamber Permanent Cardiac PacemakersNational determinationOn the books20.8.3Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Consulta Crt-P Syncra", any status and sponsor, newest update first.
No registered device study names "Consulta Crt-P Syncra".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Consulta Crt-P Syncra", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OJX
40,615 reports: 16,946 malfunction, 22,305 injury, 1,330 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2127-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Z-2128-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-2511-2020 · Started Jun 4, 2020 · Posted by FDA Jul 10, 2020
Reason given: There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check", EffectivCRT" algorithms, and AdaptivCRT"). This rare...
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
7 more recall records with a free account
Published research
The most relevant PubMed records for "Consulta Crt-P Syncra"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OJX.
- Medtronic Attain Ability Model 4196 LeadMedtronic, Inc. · PMA 2020
- Attain StarFix Model 4195 LeadMedtronic, Inc. · PMA 2018
- Attain Ability Straight Left Ventricular LeadMedtronic, Inc. · PMA 2021
- Medtronic Attain Ability Plus Left Ventricular LeadMedtronic, Inc. · PMA 2019
- Attain Performa Model 4398 and 4598 Left Ventricular LeadsMedtronic, Inc. · PMA 2014
- Insync Crt-P/Insync III CRT-PMedtronic, Inc. · PMA 2011
- Attain Stability Quad MRI SureScan LeadMedtronic, Inc. · PMA 2019
- Acuity Spiral LeadsBoston Scientific Corp · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.